Conditions: Allergic Conjunctivitis
Keywords: allergic conjunctivitis Pataday Olopatadine
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 17
Healthy volunteers: no

Brief summary:
The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.

Detailed description:
Heidelberg Retina Tomograph (HRT) will be used to descriptively evaluate the corneal structures and assess the immune cell status of allergic conjunctivitis patients pre- and post-treatment with olopatadine 0.2% in relation to a normative database.

Arms:
arm 1: Olopatadine hydrochloride ophthalmic solution, 0.2%, 1 drop once daily in both eyes for 14 days

Interventions: intervention 1: Olopatadine hydrochloride ophthalmic solution, 0.2%
Intervention descriptions: intervention 1: None

Protocol document: